165 related articles for article (PubMed ID: 32659303)
1. Novel bexarotene derivatives: Synthesis and cytotoxicity evaluation for glioma cells in 2D and 3D in vitro models.
Gretskaya NM; Gamisonia AM; Dudina PV; Zakharov SS; Sherstyanykh G; Akasov R; Burov S; Serkov IV; Akimov MG; Bezuglov VV; Markvicheva E
Eur J Pharmacol; 2020 Sep; 883():173346. PubMed ID: 32659303
[TBL] [Abstract][Full Text] [Related]
2. Bexarotene inhibits cell proliferation by inducing oxidative stress, DNA damage and apoptosis via PPARγ/ NF-κB signaling pathway in C6 glioma cells.
Hacioglu C; Kar F; Kacar S; Sahinturk V; Kanbak G
Med Oncol; 2021 Feb; 38(3):31. PubMed ID: 33599853
[TBL] [Abstract][Full Text] [Related]
3. β-asarone induces cell apoptosis, inhibits cell proliferation and decreases migration and invasion of glioma cells.
Wang N; Han Y; Luo L; Zhang Q; Ning B; Fang Y
Biomed Pharmacother; 2018 Oct; 106():655-664. PubMed ID: 29990855
[TBL] [Abstract][Full Text] [Related]
4. Modeling, Synthesis, and Biological Evaluation of Potential Retinoid-X-Receptor (RXR) Selective Agonists: Analogs of 4-[1-(3,5,5,8,8-Pentamethyl-5,6,7,8-tetrahyro-2-naphthyl)ethynyl]benzoic Acid (Bexarotene) and 6-(Ethyl(4-isobutoxy-3-isopropylphenyl)amino)nicotinic Acid (NEt-4IB).
Jurutka PW; di Martino O; Reshi S; Mallick S; Sabir ZL; Staniszewski LJP; Warda A; Maiorella EL; Minasian A; Davidson J; Ibrahim SJ; Raban S; Haddad D; Khamisi M; Suban SL; Dawson BJ; Candia R; Ziller JW; Lee MY; Liu C; Liu W; Marshall PA; Welch JS; Wagner CE
Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830251
[TBL] [Abstract][Full Text] [Related]
5. A novel selective mitochondrial-targeted curcumin analog with remarkable cytotoxicity in glioma cells.
Shi L; Gao LL; Cai SZ; Xiong QW; Ma ZR
Eur J Med Chem; 2021 Oct; 221():113528. PubMed ID: 34020339
[TBL] [Abstract][Full Text] [Related]
6. Isocostunolide inhibited glioma stem cell by suppression proliferation and inducing caspase dependent apoptosis.
Dai Z; Li SR; Zhu PF; Liu L; Wang B; Liu YP; Luo XD; Zhao XD
Bioorg Med Chem Lett; 2017 Jul; 27(13):2863-2867. PubMed ID: 28487072
[TBL] [Abstract][Full Text] [Related]
7. Expression of cyclooxygenase 2 (COX-2) in human glioma and in vitro inhibition by a specific COX-2 inhibitor, NS-398.
Joki T; Heese O; Nikas DC; Bello L; Zhang J; Kraeft SK; Seyfried NT; Abe T; Chen LB; Carroll RS; Black PM
Cancer Res; 2000 Sep; 60(17):4926-31. PubMed ID: 10987308
[TBL] [Abstract][Full Text] [Related]
8. Discovering alkylamide derivatives of bexarotene as new therapeutic agents against triple-negative breast cancer.
Chen L; Long C; Nguyen J; Kumar D; Lee J
Bioorg Med Chem Lett; 2018 Feb; 28(3):420-424. PubMed ID: 29287960
[TBL] [Abstract][Full Text] [Related]
9. Repurposing FDA approved drugs inhibiting mitochondrial function for targeting glioma-stem like cells.
Datta S; Sears T; Cortopassi G; Woolard K; Angelastro JM
Biomed Pharmacother; 2021 Jan; 133():111058. PubMed ID: 33378970
[TBL] [Abstract][Full Text] [Related]
10. The effects of tibolone on the human primary glioblastoma multiforme cell culture and the rat C6 glioma model.
Altinoz MA; Albayrak SB; Karasu A; Sabanci PA; Imer M; Bilir A
Neurol Res; 2009 Nov; 31(9):923-7. PubMed ID: 19531283
[TBL] [Abstract][Full Text] [Related]
11. A novel 96-well multielectrode array based impedimetric monitoring platform for comparative drug efficacy analysis on 2D and 3D brain tumor cultures.
Eichler M; Jahnke HG; Krinke D; Müller A; Schmidt S; Azendorf R; Robitzki AA
Biosens Bioelectron; 2015 May; 67():582-9. PubMed ID: 25445619
[TBL] [Abstract][Full Text] [Related]
12. Effect of bexarotene on differentiation of glioblastoma multiforme compared with ATRA.
Heo JC; Jung TH; Lee S; Kim HY; Choi G; Jung M; Jung D; Lee HK; Lee JO; Park JH; Hwang D; Seol HJ; Cho H
Clin Exp Metastasis; 2016 Jun; 33(5):417-29. PubMed ID: 26957434
[TBL] [Abstract][Full Text] [Related]
13. Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel.
Bayat N; Ebrahimi-Barough S; Norouzi-Javidan A; Saberi H; Tajerian R; Ardakan MMM; Shirian S; Ai A; Ai J
Biomed Pharmacother; 2016 Dec; 84():1959-1966. PubMed ID: 27836464
[TBL] [Abstract][Full Text] [Related]
14. A novel 3D human glioblastoma cell culture system for modeling drug and radiation responses.
Gomez-Roman N; Stevenson K; Gilmour L; Hamilton G; Chalmers AJ
Neuro Oncol; 2017 Feb; 19(2):229-241. PubMed ID: 27576873
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic effects of sodium butyrate on glioma cells in vitro and in the rat C6 glioma model.
Engelhard HH; Duncan HA; Kim S; Criswell PS; Van Eldik L
Neurosurgery; 2001 Mar; 48(3):616-24; discussion 624-5. PubMed ID: 11270553
[TBL] [Abstract][Full Text] [Related]
16. Quercetin derivative induces cell death in glioma cells by modulating NF-κB nuclear translocation and caspase-3 activation.
Kiekow CJ; Figueiró F; Dietrich F; Vechia LD; Pires EN; Jandrey EH; Gnoatto SC; Salbego CG; Battastini AM; Gosmann G
Eur J Pharm Sci; 2016 Mar; 84():116-22. PubMed ID: 26802551
[TBL] [Abstract][Full Text] [Related]
17. Lipopolysaccharide plus 12-o-tetradecanoylphorbol 13-acetate induction of migration and invasion of glioma cells in vitro and in vivo: Differential inhibitory effects of flavonoids.
Shen SC; Lin CW; Lee HM; Chien LL; Chen YC
Neuroscience; 2006 Jun; 140(2):477-89. PubMed ID: 16580779
[TBL] [Abstract][Full Text] [Related]
18. Flavonoids from the Amazon plant Brosimum acutifolium induce C6 glioma cell line apoptosis by disrupting mitochondrial membrane potential and reducing AKT phosphorylation.
Maués LAL; Alves GM; Couto NMG; da Silva BJM; Arruda MSP; Macchi BM; Sena CBC; Prado AF; Crespo-Lopez ME; Silva EO; do Nascimento JLM
Biomed Pharmacother; 2019 May; 113():108728. PubMed ID: 30856536
[TBL] [Abstract][Full Text] [Related]
19. Enhanced cell growth and tumorigenicity of rat glioma cells by stable expression of human CD133 through multiple molecular actions.
Fang KM; Lin TC; Chan TC; Ma SZ; Tzou BC; Chang WR; Liu JJ; Chiou SH; Yang CS; Tzeng SF
Glia; 2013 Sep; 61(9):1402-17. PubMed ID: 23832679
[TBL] [Abstract][Full Text] [Related]
20. NVP-BEZ235, a novel dual PI3K-mTOR inhibitor displays anti-glioma activity and reduces chemoresistance to temozolomide in human glioma cells.
Yu Z; Xie G; Zhou G; Cheng Y; Zhang G; Yao G; Chen Y; Li Y; Zhao G
Cancer Lett; 2015 Oct; 367(1):58-68. PubMed ID: 26188279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]